NantHealth – $107 Million Notes Offering

San Diego – January 11, 2017 – Cooley advised the initial purchasers on NantHealth’s $107 million offering of aggregate principal amount of 5.50% convertible senior notes due 2021, including a separate concurrent $10 million private placement and $7 million of option notes.

JP Morgan and Jefferies acted as joint book-running managers for the offering, Cowen and Company acted as lead manager and Canaccord Genuity acted as co-manager.

NantHealth, which trades on the NASDAQ Global Select Market under the symbol “NH,” is a next generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses.

Cooley previously advised the underwriters on NantHealth’s $97 million IPO.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

Related Contacts
Charlie Kim  Partner San Diego, Los Angeles – Santa Monica
David Peinsipp  Partner San Francisco, Palo Alto
Kristin VanderPas  Partner San Francisco
Carlos Ramirez  Partner San Diego
Mischi a Marca  Partner San Francisco
Natasha Leskovsek  Of Counsel Washington, DC
Phil Mitchell  Partner New York
Bill Christiansen  Partner Seattle
Kevin King  Partner Washington, DC
Shannon Eagan  Partner in Charge – Palo Alto Palo Alto
Francis Wheeler  Partner Colorado
Randy Sabett  Special Counsel Washington, DC
Jason Savich  Partner San Francisco
Karen Tsai  Special Counsel Washington, DC